Ranbaxy (UK) Ltd

SME

Has won 61 UK public-sector contracts worth £14.3m across 5 buyers, primarily NHS England.

⇄ Compare peers ⇩ Export ↗ Share

Active contracts

no new awards in 30d

Contracted (12m)

—

no data

Public buyers

61 contracts total

Top buyer share

56%

NHS England

Buyer concentration

Each block sized by share of total award value. A dominant block signals dependency on one buyer.

Severe concentration. Top buyer alone = 56% of revenue.

NHS England

£8.0m

56%

Department of Health and Social Care (DHSC)

£5.4m

38%

NHS England and NHS Improvement

£944k

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

—

The NHS Commissioning Board (operating under the name of NHS England)

—

Contracts won · 61 total · 50 active · 11 expired

Every contract award published under the Procurement Act.

Sort

Title	Buyer	Award type	Value	Awarded	Status
NHS Framework Agreement for Branded medicines - National	NHS England	Framework call off	£6.1m ceiling · ~£71k share (÷86)	16 May 2022	expired
Supportive Medicines including ITU, EOL & Antibiotics	Department of Health and Social Care (DHSC)	Framework call off	£1.7m ceiling · ~£52k share (÷32)	14 Sept 2020	expired
Supportive Medicines including ITU, EOL & Antibiotics	Department of Health and Social Care (DHSC)	Framework call off	£1.7m ceiling · ~£52k share (÷32)	14 Sept 2020	expired
Supportive Medicines including ITU, EOL & Antibiotics	Department of Health and Social Care (DHSC)	Framework call off	£1.7m ceiling · ~£52k share (÷32)	14 Sept 2020	expired
NHS National Pharmaceuticals Transition 2022_1	NHS England and NHS Improvement	Framework call off	£944k ceiling · ~£22k share (÷42)	19 Jul 2022	expired
NHS National Pharmaceuticals Transition 2021_3	NHS England	Shared contract	£722k lot total · 36 suppliers	22 Oct 2021	expired
NHS National Generic Pharmaceuticals- Transition 2021_1	NHS England	Shared contract	£443k lot total · 20 suppliers	03 Mar 2021	expired
Contract for the supply of Antibiotics and IV Fluids under a Dynamic Purchasing System	Department of Health and Social Care (DHSC)	Shared contract	£388k lot total · 8 suppliers	28 Apr 2021	expired
NHS National Pharmaceuticals - Everolimus and terminated agreement products	NHS England	Shared contract	£301k lot total · 15 suppliers	08 Jun 2021	expired
NHS National Generic Pharmaceuticals Interim 2	NHS England	Shared contract	£242k lot total · 51 suppliers	21 Dec 2020	expired
NHS National Generic Pharmaceuticals - Transition 2021_2	NHS England	Shared contract	£163k lot total · 17 suppliers	01 Apr 2021	expired
Oncology Generics Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Direct contract	—	—	active
Oncology Generics Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Direct contract	—	—	active
Oncology Generics Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 23 suppliers	—	active
NHS National Generic Pharmaceuticals Interim 2 2020	The NHS Commissioning Board (operating under the name of NHS England)	Direct contract	—	—	active

Showing 1–15 of 61

Ranbaxy (UK) Ltd

Buyer concentration

Contracts won · 61 total · 50 active · 11 expired

Top buyers · by total award value

Category mix — CPV divisions

Geographic spread

Modifications received · scope growth on existing wins

Compliance scorecard

Financial health

Company information

Corporate structure

Peer suppliers

News mentions

Ranbaxy (UK) Ltd

Why Capita's public-sector share keeps slipping — and who's eating it

The 12 frameworks Capita bid on last year (and lost 8)

Is BPO concentration back? A supplier-risk deep-dive